These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 29787777

  • 1. Examination of the effects of cannabinoid ligands on decision making in a rat gambling task.
    Ferland JN, Carr MR, Lee AM, Hoogeland ME, Winstanley CA, Pattij T.
    Pharmacol Biochem Behav; 2018 Jul; 170():87-97. PubMed ID: 29787777
    [Abstract] [Full Text] [Related]

  • 2. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P, Teimuri Far M.
    Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
    [Abstract] [Full Text] [Related]

  • 3. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 4. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.
    Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
    [Abstract] [Full Text] [Related]

  • 5. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I.
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats.
    Solinas M, Panlilio LV, Tanda G, Makriyannis A, Matthews SA, Goldberg SR.
    Neuropsychopharmacology; 2005 Nov 01; 30(11):2046-57. PubMed ID: 15870833
    [Abstract] [Full Text] [Related]

  • 8. Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats.
    De Carvalho CR, Pamplona FA, Cruz JS, Takahashi RN.
    Psychopharmacology (Berl); 2014 Apr 01; 231(7):1417-25. PubMed ID: 24247477
    [Abstract] [Full Text] [Related]

  • 9. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
    Araya KA, David Pessoa Mahana C, González LG.
    Eur J Pharmacol; 2007 Oct 15; 572(1):32-9. PubMed ID: 17644088
    [Abstract] [Full Text] [Related]

  • 10. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM, Eisenstein SA, Astarita G, Piomelli D, Hohmann AG.
    Psychopharmacology (Berl); 2008 Oct 15; 200(3):333-46. PubMed ID: 18545985
    [Abstract] [Full Text] [Related]

  • 11. Cannabinoid CB1 receptor activation mediates the opposing effects of amphetamine on impulsive action and impulsive choice.
    Wiskerke J, Stoop N, Schetters D, Schoffelmeer AN, Pattij T.
    PLoS One; 2011 Oct 15; 6(10):e25856. PubMed ID: 22016780
    [Abstract] [Full Text] [Related]

  • 12. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats.
    Pattij T, Janssen MC, Schepers I, González-Cuevas G, de Vries TJ, Schoffelmeer AN.
    Psychopharmacology (Berl); 2007 Jul 15; 193(1):85-96. PubMed ID: 17387457
    [Abstract] [Full Text] [Related]

  • 13. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
    Hansson AC, Bermúdez-Silva FJ, Malinen H, Hyytiä P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, Heilig M.
    Neuropsychopharmacology; 2007 Jan 15; 32(1):117-26. PubMed ID: 16482090
    [Abstract] [Full Text] [Related]

  • 14. Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.
    Järbe TU, LeMay BJ, Halikhedkar A, Wood J, Vadivel SK, Zvonok A, Makriyannis A.
    Psychopharmacology (Berl); 2014 Feb 15; 231(3):489-500. PubMed ID: 24005529
    [Abstract] [Full Text] [Related]

  • 15. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel SK, Makriyannis A, Goldberg SR.
    J Pharmacol Exp Ther; 2007 Apr 15; 321(1):370-80. PubMed ID: 17210800
    [Abstract] [Full Text] [Related]

  • 16. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA, Xu Z, Kulkarni PM, Pertwee RG, Mackie K, Thakur GA, Hohmann AG.
    Biol Psychiatry; 2018 Nov 15; 84(10):722-733. PubMed ID: 28823711
    [Abstract] [Full Text] [Related]

  • 17. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling.
    Su SH, Wang YQ, Wu YF, Wang DP, Lin Q, Hai J.
    Behav Brain Res; 2016 Oct 15; 313():334-344. PubMed ID: 27424778
    [Abstract] [Full Text] [Related]

  • 18. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
    Kangas BD, Leonard MZ, Shukla VG, Alapafuja SO, Nikas SP, Makriyannis A, Bergman J.
    J Pharmacol Exp Ther; 2016 Apr 15; 357(1):125-33. PubMed ID: 26826191
    [Abstract] [Full Text] [Related]

  • 19. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB.
    Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 24; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.